Australia's MedAdvisor eyes best day in 10-mnths on strategic options evaluation

Adheris Health

14/11/2024 01:29

** Shares of MedAdvisor  MDR.AX  rise 18% to A$0.295, on
track for its best session since Jan. 8, if current trends hold
    ** Stock hit its highest level since Oct. 31
    ** Medical software co initiates formal review process to
evaluate strategic options to maximize shareholder value
    ** Stock has risen 16.3% YTD, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))